http://rdf.disgenet.org/resource/nanopub/NP198969.RAbkdBGBgJruRY8JBZMqU9BuRhhyRIsWaecrAGknnfJsk
type: Nanopublication
created: 2016-05-13T12:43:17+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetv3.0rdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v4.0.0.0

http://rdf.disgenet.org/resource/nanopub/NP198969.RAbkdBGBgJruRY8JBZMqU9BuRhhyRIsWaecrAGknnfJsk130_assertion
type: Assertion
description: [TNF-alpha (/IFN-gamma) treatment up-regulates the expression of the NOD2 gene in intestinal epithelial cells and this, with nod2 mutations, could be part of the complex pathophysiology of barrier disruption as it is observed in inflammatory bowel diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/12671897
was generated by: ECO_0000203

lhgdn-20090331
imported on: 2009-03-31

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetv3.0rdf
version: v4.0.0